title: Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women.
abstract: In women there is an increase in visceral obesity, subcutaneous abdominal adipocyte lipolysis, and risk of cardiovascular disease (CVD) associated with weight gain after menopause. The mechanisms underlying this increase in adrenoreceptor (AR)-agonist catecholamine-stimulated lipolysis and abdominal obesity in postmenopausal women were studied in intact adipocytes isolated from the abdominal and gluteal subcutaneous fat depots in 19 obese (48% +/- 1% body fat, mean +/- SE) women with a mean +/- SE age of 58 +/- 1 years. The fat cell size and adipose tissue lipoprotein lipase (ATLPL) activity were similar in both sites. The maximal lipolytic responsiveness and sensitivity to isoproterenol were higher (P < .05) in abdominal compared with gluteal adipocytes, but maximal lipolytic response to a post-AR agent was similar. Abdominal adipocytes had a higher beta-AR ([3H]-CGP-12177) and alpha2-AR ([3H]-yohimbine) affinity than gluteal cells (P < .05), lower alpha2-AR density (P < .05), but similar beta-AR density as gluteal cells. Both abdominal and gluteal cell size correlated with alpha2-AR density (P < .01), but not with beta-AR density. Thus, a higher beta-AR affinity and lower alpha2-AR relative to beta-AR density may explain the higher in vitro catecholamine-mediated lipolysis in abdominal compared with gluteal adipocytes in obese, postmenopausal women.
authors.affiliation: Department of Medicine, University of Maryland School of Medicine; the Geriatric Research, Education and Clinical Center, Baltimore Veterans Affair Medical Center, 21201, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Berman
authors.forename: B J
authors.initials: BJ
authors.lastname: Nicklas
authors.forename: E M
authors.initials: EM
authors.lastname: Rogus
authors.forename: K E
authors.initials: KE
authors.lastname: Dennis
authors.forename: A P
authors.initials: AP
authors.lastname: Goldberg
mesh_terms: D017667:Adipocytes / Q000502:physiology*; D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000368:Aged; D048429:Cell Size; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008066:Lipolysis / Q000502:physiology*; D008875:Middle Aged; D009765:Obesity / Q000503:physiopathology*; D017698:Postmenopause / Q000502:physiology*; D018341:Receptors, Adrenergic, alpha-2 / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*
chemical_list: D000318:Adrenergic beta-Agonists; D018341:Receptors, Adrenergic, alpha-2; D011943:Receptors, Adrenergic, beta; D007545:Isoproterenol